S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech
$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...
325 Views
S&P 500 and S&P 600 Testing Resistance...Still
The S&P 500 is beginning to come off of short-term overbought extremes, consolidating near the confluence of key overhead resistance and the...
200 Views
Innovation to Help Maintain HIV Franchise Market Share and Weather Harsh Domestic Market Conditions
Continuous innovation at HIV Franchise to not only help defend market share…. Concerns about competition from Gilead Sciences Inc (GILD US)'s,...
121 Views
New Long Position: Gene Therapy for Parkinson's Disease and Upcoming Catalysts
Our next long position is Voyager Therapeutics Inc (VYGR US) , a Cambridge, Massachusetts-based emerging biotechnology company that is developing...
448 Views